MedPath

Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia

Completed
Conditions
Esophagitis
Interventions
Procedure: EGD with biopsies
Registration Number
NCT00256529
Lead Sponsor
University of Utah
Brief Summary

This is a prospective descriptive cross sectional study to determine the percentage of patients presenting with dysphagia who are found to have eosinophilic esophagitis (EoE) and to establish which presenting factors warrant esophageal biopsies. We hypothesize that a greater than expected percentage of patients who are biopsies will have histologic changes consistent with EE.

Detailed Description

All patients presenting with dysphagia who do not already carry a previous diagnosis for their dysphagia will be asked to enroll. If patients have undergone previous work up for dysphagia such as manometry, 24-hour probe, or barium swallow they can still participate in this study. Informed consent will take place prior to enrollment. After patients present with dysphagia they will fill-out a questionnaire regarding their dysphagia symptoms. An EGD with biopsies will then be performed. Biopsies will be taken from 4 quadrants in the proximal and distal esophagus. The distal esophagus biopsies will be taken 5 cm proximal to the Z-line. Proximal biopsies will be taken anywhere proximal to 30 cm from the incisors.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
483
Inclusion Criteria
  • Patients aged 18-90 presenting with dysphagia or food impaction
  • Ability to undergo esophagogastroduodenoscopy and biopsies
  • No significant cardiopulmonary disease, or other contraindication to EGD
Exclusion Criteria
  • Contradiction to EGD and/or biopsies such as Boerhaave's syndrome, or history or bleeding disorder or elevated INR
  • Inability to provide informed consent
  • Esophageal varices

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
IEGD with biopsiesAll subjects presenting in with dysphagia will be in this cohort.
Primary Outcome Measures
NameTimeMethod
To assess the percentage of patients who present with dysphagia who have EE by histologic criteriaDecember 2010
Secondary Outcome Measures
NameTimeMethod
To assess the demographics of the EE patients with dysphagiaDecember 2010
To assess percentage of EE patients with recurrent, versus acute dysphagiaDecember 2010
To measure the frequency, severity, and time course of dysphagia in patients with EEDecember 2010

Trial Locations

Locations (1)

Department of Veterans Affairs

🇺🇸

Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath